AI-Bio is located in the Linping Economic and Technological Development Zone, Hangzhou. With a focus on addressing critical clinical needs in oncology, central nervous system (CNS) disorders, and autoimmune- inflammatory diseases that remain unsolved, the company is driven by technological innovation and centered on precise drug design. By integrating advanced technologies and strategies in artificial intelligence, medicinal chemistry, and biology, AI-Bio is dedicated to develope innovative drugs with novel mechanisms of action and outstanding clinical value.